Onconetix Inc (ONCO NASDAQ) stock market data APIs
$3.4699
0.02(0.6%)
as of July 18, 2025
Try our APIs with
free plan!
Onconetix Inc Financial Data Overview
Price chart is built with
Anychart
Onconetix, Inc., a biotechnology company, focuses on the research, development, and commercialization of solutions for men's health and oncology in the United States, European Union, and Non-European Union. The company offers Proclarix, an in vitro protein-based blood diagnostic test for prostate cancer. It has a license agreement with LabCorp to develop and commercialize Proclarix and other products. The company was formerly known as Blue Water Biotech, Inc. and changed its name to Onconetix, Inc. in December 2023. Onconetix, Inc. was founded in 2018 and is headquartered in Cincinnati, Ohio.
Prev. Close
3.4699
Open
3.4933
High
3.5149
Low
3.2695
52 wk Range
3.16-656.2
Market Cap
1 795 K
Shares Outstanding
522 K
Revenue
1 925 K
EPS
-45.44
Beta
3.509
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Onconetix Inc data using free add-ons & libraries
Get Onconetix Inc Fundamental Data
Onconetix Inc Fundamental data includes:
- Net Revenue: 1 925 K
- EBITDA: -5 658 265
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-05-30
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Onconetix Inc News
New
$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Onconetix, Inc. (NASDAQ: ONCO)
NEW YORK, July 17, 2025 (GLOBE NEWSWIRE) -- Class Action Attorney Juan Monteverde with Monteverde & Associates PC (the “M&A Class Action Firm”), has recovered millions of dollars for shareholde...
Onconetix to buy privately held Ocuvex Therapeutics
[Two puzzle pieces connecting, one white and one grey, on a contrasting background.] mohd izzuan/iStock via Getty Images * Onconetix (NASDAQ:ONCO [https://seekingalpha.com/symbol/ONCO]) announced o...
Onconetix and Ocuvex Therapeutics announce execution of definitive merger agreement
CINCINNATI, July 16, 2025 (GLOBE NEWSWIRE) -- Onconetix, Inc. (Nasdaq: ONCO) (“Onconetix” or the “Company”) and Ocuvex Therapeutics, Inc. (“Ocuvex”), a privately held biopharmaceutical c...
Onconetix, Inc. Announces Positive Decision by Nasdaq Hearings Panel
CINCINNATI, Ohio, June 16, 2025 (GLOBE NEWSWIRE) -- Onconetix, Inc. (Nasdaq: ONCO) (“Onconetix” or the “Company”), a commercial-stage biotechnology company focused on the research, developm...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
